Global T Cell Specific Surface Glycoprotein CD28 Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of T Cell Specific Surface Glycoprotein CD28

• 1.1 Definition of T Cell Specific Surface Glycoprotein CD28
• 1.2 T Cell Specific Surface Glycoprotein CD28 Segment by Type
  • 1.2.1 Global T Cell Specific Surface Glycoprotein CD28 Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 FPT-155
  • 1.2.3 FR-104
  • 1.2.4 Lulizumab Pegol
  • 1.2.5 Others
• 1.3 T Cell Specific Surface Glycoprotein CD28 Segment by Applications
  • 1.3.1 Global T Cell Specific Surface Glycoprotein CD28 Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Plaque Psoriasis
  • 1.3.3 Solid Tumor
  • 1.3.4 Acute Renal Failure(ARF)
  • 1.3.5 Others
• 1.4 Global T Cell Specific Surface Glycoprotein CD28 Overall Market
  • 1.4.1 Global T Cell Specific Surface Glycoprotein CD28 Revenue (2014-2025)
  • 1.4.2 Global T Cell Specific Surface Glycoprotein CD28 Production (2014-2025)
  • 1.4.3 North America T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
  • 1.4.4 Europe T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
  • 1.4.5 China T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
  • 1.4.6 Japan T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)
  • 1.4.8 India T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of T Cell Specific Surface Glycoprotein CD28
• 2.3 Manufacturing Process Analysis of T Cell Specific Surface Glycoprotein CD28
• 2.4 Industry Chain Structure of T Cell Specific Surface Glycoprotein CD28

3 Development and Manufacturing Plants Analysis of T Cell Specific Surface Glycoprotein CD28

• 3.1 Capacity and Commercial Production Date
• 3.2 Global T Cell Specific Surface Glycoprotein CD28 Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of T Cell Specific Surface Glycoprotein CD28
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 T Cell Specific Surface Glycoprotein CD28 Production and Capacity Analysis
• 4.2 T Cell Specific Surface Glycoprotein CD28 Revenue Analysis
• 4.3 T Cell Specific Surface Glycoprotein CD28 Price Analysis
• 4.4 Market Concentration Degree

5 T Cell Specific Surface Glycoprotein CD28 Regional Market Analysis

• 5.1 T Cell Specific Surface Glycoprotein CD28 Production by Regions
  • 5.1.1 Global T Cell Specific Surface Glycoprotein CD28 Production by Regions
  • 5.1.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Regions
• 5.2 T Cell Specific Surface Glycoprotein CD28 Consumption by Regions
• 5.3 North America T Cell Specific Surface Glycoprotein CD28 Market Analysis
  • 5.3.1 North America T Cell Specific Surface Glycoprotein CD28 Production
  • 5.3.2 North America T Cell Specific Surface Glycoprotein CD28 Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America T Cell Specific Surface Glycoprotein CD28 Import and Export
• 5.4 Europe T Cell Specific Surface Glycoprotein CD28 Market Analysis
  • 5.4.1 Europe T Cell Specific Surface Glycoprotein CD28 Production
  • 5.4.2 Europe T Cell Specific Surface Glycoprotein CD28 Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe T Cell Specific Surface Glycoprotein CD28 Import and Export
• 5.5 China T Cell Specific Surface Glycoprotein CD28 Market Analysis
  • 5.5.1 China T Cell Specific Surface Glycoprotein CD28 Production
  • 5.5.2 China T Cell Specific Surface Glycoprotein CD28 Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China T Cell Specific Surface Glycoprotein CD28 Import and Export
• 5.6 Japan T Cell Specific Surface Glycoprotein CD28 Market Analysis
  • 5.6.1 Japan T Cell Specific Surface Glycoprotein CD28 Production
  • 5.6.2 Japan T Cell Specific Surface Glycoprotein CD28 Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan T Cell Specific Surface Glycoprotein CD28 Import and Export
• 5.7 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Market Analysis
  • 5.7.1 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Production
  • 5.7.2 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Import and Export
• 5.8 India T Cell Specific Surface Glycoprotein CD28 Market Analysis
  • 5.8.1 India T Cell Specific Surface Glycoprotein CD28 Production
  • 5.8.2 India T Cell Specific Surface Glycoprotein CD28 Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India T Cell Specific Surface Glycoprotein CD28 Import and Export

6 T Cell Specific Surface Glycoprotein CD28 Segment Market Analysis (by Type)

• 6.1 Global T Cell Specific Surface Glycoprotein CD28 Production by Type
• 6.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Type
• 6.3 T Cell Specific Surface Glycoprotein CD28 Price by Type

7 T Cell Specific Surface Glycoprotein CD28 Segment Market Analysis (by Application)

• 7.1 Global T Cell Specific Surface Glycoprotein CD28 Consumption by Application
• 7.2 Global T Cell Specific Surface Glycoprotein CD28 Consumption Market Share by Application (2014-2019)

8 T Cell Specific Surface Glycoprotein CD28 Major Manufacturers Analysis

• 8.1 Atox Bio Ltd
  • 8.1.1 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
  • 8.1.2 Atox Bio Ltd Product Introduction, Application and Specification
  • 8.1.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Bristol-Myers Squibb Co
  • 8.2.1 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
  • 8.2.2 Bristol-Myers Squibb Co Product Introduction, Application and Specification
  • 8.2.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Five Prime Therapeutics Inc
  • 8.3.1 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
  • 8.3.2 Five Prime Therapeutics Inc Product Introduction, Application and Specification
  • 8.3.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Johnson & Johnson
  • 8.4.1 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
  • 8.4.2 Johnson & Johnson Product Introduction, Application and Specification
  • 8.4.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 TheraMAB LLC
  • 8.5.1 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Production Sites and Area Served
  • 8.5.2 TheraMAB LLC Product Introduction, Application and Specification
  • 8.5.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of T Cell Specific Surface Glycoprotein CD28 Market

• 9.1 Global T Cell Specific Surface Glycoprotein CD28 Market Trend Analysis
  • 9.1.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size (Volume and Value) Forecast 2019-2025
• 9.2 T Cell Specific Surface Glycoprotein CD28 Regional Market Trend
  • 9.2.1 North America T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
  • 9.2.2 Europe T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
  • 9.2.3 China T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
  • 9.2.4 Japan T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
  • 9.2.5 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
  • 9.2.6 India T Cell Specific Surface Glycoprotein CD28 Forecast 2019-2025
• 9.3 T Cell Specific Surface Glycoprotein CD28 Market Trend (Product Type)
• 9.4 T Cell Specific Surface Glycoprotein CD28 Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 T Cell Specific Surface Glycoprotein CD28 Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List